Trends in 30-Day Readmission Rates for Patients Hospitalized With Heart Failure: Findings From the Get With The Guidelines-Heart Failure Registry
about
A Phase 2a dose-escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS-986231 in hospitalized patients with heart failure with reduced ejection fraction.Palliative Care in Heart Failure: The PAL-HF Randomized, Controlled Clinical Trial.Obstructive sleep apnea is associated with increased readmission in heart failure patients.A machine learning model to predict the risk of 30-day readmissions in patients with heart failure: a retrospective analysis of electronic medical records data.Association between loop diuretic dose administered in first 24 hours of heart failure admissions and length of hospital stay
P2860
Trends in 30-Day Readmission Rates for Patients Hospitalized With Heart Failure: Findings From the Get With The Guidelines-Heart Failure Registry
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Trends in 30-Day Readmission R ...... delines-Heart Failure Registry
@en
Trends in 30-Day Readmission R ...... elines-Heart Failure Registry.
@nl
type
label
Trends in 30-Day Readmission R ...... delines-Heart Failure Registry
@en
Trends in 30-Day Readmission R ...... elines-Heart Failure Registry.
@nl
prefLabel
Trends in 30-Day Readmission R ...... delines-Heart Failure Registry
@en
Trends in 30-Day Readmission R ...... elines-Heart Failure Registry.
@nl
P2093
P2860
P50
P1476
Trends in 30-Day Readmission R ...... delines-Heart Failure Registry
@en
P2093
Adrian F Hernandez
Christine Ju
Deepak L Bhatt
Kristin E Bergethon
N Chantelle Hardy
Paul A Heidenreich
P2860
P356
10.1161/CIRCHEARTFAILURE.115.002594
P577
2016-06-01T00:00:00Z